These Analysts Revise Their Forecasts On ABM Following Q3 Results

ABM Industries Inc. reported mixed fiscal Q3 2025 results, with revenue of $2.22 billion exceeding analyst estimates of $2.15 billion, but adjusted EPS of $0.82 missing the $0.95 consensus. The company narrowed its fiscal 2025 adjusted EPS outlook to $3.65, the low end of its prior range and below analyst estimates, leading to a 2% decline in shares. While management anticipates Q4 improvements from restructuring and strong Technical Solutions performance, analyst reactions were split, with Baird downgrading the stock and cutting its price target, while UBS maintained a Buy rating and slightly raised its target.

Analysis

ABM Industries (ABM) reported mixed fiscal third-quarter 2025 results, characterized by a top-line beat but a bottom-line miss and cautious forward guidance. Revenue grew 6.2% year-over-year to $2.22 billion, surpassing the $2.15 billion analyst consensus, with the company highlighting organic growth across all segments. However, adjusted EPS of $0.82 fell short of the $0.95 estimate and represented a slight decline from the prior year's $0.84. This profitability shortfall prompted a narrowing of the full-year 2025 adjusted EPS outlook to $3.65, the low end of its previous range and below the $3.75 analyst forecast. Despite the tempered outlook, management points to a strong future pipeline, evidenced by a 15% year-over-year increase in new bookings, and anticipates a meaningful improvement in fourth-quarter margins and EPS, driven by restructuring savings and performance in its Technical Solutions segment. The market reacted negatively, with shares falling 2%, and analyst sentiment was divided, as Baird downgraded the stock to Neutral while UBS maintained a Buy rating, reflecting the conflicting signals between current profitability pressures and future growth potential.

Key Decisions for Investors

• Investors should weigh the company's strong revenue growth and a 15% increase in new bookings against the significant Q3 earnings miss and downward revision of full-year EPS guidance, which signals persistent margin pressure.
• Monitor the upcoming fourth quarter results for evidence of the 'meaningful' margin and EPS improvement management anticipates, as execution on restructuring savings and Technical Solutions performance is critical to validating the bull case.
• Given the conflicting signals and divergent analyst ratings from Baird (Neutral) and UBS (Buy), a hold position may be prudent until there is clearer evidence that the company can convert its top-line strength into improved profitability.